Innate Pharma S.A. (EPA: IPH)
2.090
-0.020 (-0.95%)
Aug 30, 2024, 5:35 PM CET
Innate Pharma Revenue
Innate Pharma had revenue of 165.52M EUR in the half year ending February 29, 2024, with 81.11% growth. This brings the company's revenue in the last twelve months to 331.52M, up 36.80% year-over-year. In the fiscal year ending August 31, 2023, Innate Pharma had annual revenue of 278.34M with 25.72% growth.
Revenue (ttm)
331.52M
Revenue Growth
+36.80%
P/S Ratio
2.73
Revenue / Employee
344.36K
Employees
179
Market Cap
169.19M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Aug 31, 2023 | 278.34M | 56.94M | 25.72% |
Aug 31, 2022 | 221.40M | 17.43M | 8.55% |
Aug 31, 2021 | 203.97M | 29.41M | 16.85% |
Aug 31, 2020 | 174.56M | -34.47M | -16.49% |
Aug 31, 2019 | 209.03M | 70.70M | 51.11% |
Aug 31, 2018 | Pro | Pro | Pro |
Aug 31, 2017 | Pro | Pro | Pro |
Aug 31, 2016 | Pro | Pro | Pro |
Aug 31, 2015 | Pro | Pro | Pro |
Aug 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionInnate Pharma News
- 4 weeks ago - Innate Pharma Announces Its Participation in Upcoming Investor Conference - Business Wire
- 2 months ago - Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial - Business Wire
- 3 months ago - Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides - Business Wire
- 3 months ago - Innate Pharma Announces Its Participation in Upcoming Investor Conferences - Business Wire
- 3 months ago - Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting - Business Wire
- 3 months ago - Outcome of Innate Pharma's 2024 Annual General Meeting - Business Wire
- 3 months ago - Innate Pharma: Clarification Regarding SAR443579 Designation - Business Wire
- 3 months ago - Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress - Business Wire